Services

Today’s R&D trends are immunotherapies, personalized medicine and treatments for rare diseases. Aside from high costs tied to R&D, these treatments require advanced expertise. Developing high-tech in-house infrastructure and expanding the staff count with specific expertise is not only costly but also risky for pharmaceutical companies. Maintaining the most important core competencies, while outsourcing large parts of R&D programs to specialized, well-equipped CROs is a winning strategy.